From poo to precision: AI-powered colorectal cancer detection

As a breakthrough AI-based test, CanSense-CRC moves the needle towards improved cancer survival through early cancer stage analyte detection in line with the NHS Long Term Plan ambition to detect 75% of cancers at stage I/II by 2028. The CanSense-CRC test has the potential to rebalance the current socioeconomic inequality around testing in the UK and other countries with cancer detection challenges where colonoscopy resources are limited and by offering an alternative to faecal testing.